Amarin Corp Plc (AMRN)

[Mellowmood77]

I think the FDA knows now with 100 percent certainty that EPA is a game changer.

I suspect that they have information in the sNDA not made public in the reduce-it trial. Certain markers that improved with EPA + statin rather than statin alone.

The FDA wants desperately to tackle heart disease. They are desperate for new drugs in the area:

https://www.fda.gov/news-events/fda-brief/fda-brief-fda-takes-steps-spark-development-heart-failure-drugs

IMHO they want as many people on this drug as possible and also IMHO the label will be better than most people here expect.

I believe there will be more people on Vascepa, that aren’t on statins, than people think.